Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand

Por Oldenburg, J, Zimmermann, R, Katsarou, O, Theodossiades, G, Zanon, E, Niemann, B, Kellermann, E, Lundin, B
Publicado no Haemophilia (2015)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients

Por Vernikos, P, Xanthis, D, Georgiou, S, Archontoulis, N, Mega, A, Rigas, K, Pavleas, J, Katsarou, O, Thomopoulos, G
Publicado em 2004